RecruitingNCT07633080
Magnesium added to antidepressant treatment for depression
About this title
Read the official source — NCT07633080Placebo comparisonAges 18–65India
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- BhubaneswarSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 12, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 84
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Sponsor type
- Research institute
- Study type
- Other
- Intervention type
- Dietary supplement, Other
- Locations
- India
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07633080
- Official title
Show the full official title
Efficacy and Safety of Add-on Magnesium Bisglycinate in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Bhubaneswar
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
